Baroness Susan Greenfield sharing her perspective with Esther Reynal de St Michel Richardot on these important topics: Healthcare-related challenges that policy making is trying to address How it is impacting how innovations can reach patients The importance of having...
At Neuro-Bio, we’re thrilled at entering this next phase of development with Aptamer Group: the first phase proved productive and very promising. Now, this next stage takes us closer to realising a highly novel and much needed technology for detecting...
Our CEO Susan Greenfield and Operations Direction Sara Garcia-Rates, joined Xenopat for a face-to-face meeting in Barcelona where they shared the progress made for the Tecniospring Industry project “Development of a T14 Inhibitor for Treatment of ColoRectal Cancer”,...
The event (8th February 2024) is part of Ultima Hora’s conference series titled “Values” and is jointly organised with the University if the Balearic Islands. On this occasion, it is focused on exploring the future of technology, the internet, its...
To read more on the debate and what will be discussed, please click on the links below: https://parliamentlive.tv/Event/Index/944cbedf-d4e1-4b47-9d82-9f5f3762e2a1 https://www.alzheimers.org.uk/sites/default/files/2024-01/240118 Alzheimer%27s Society Briefing –...
Sara Garcia Rates and Javier Audibert were pleased to discuss around the table the tactics involved in successful grant applications and how to best make use of experience. The methodology of preparing a pitch to convince investors that you have the outlay to provide...
Winners of £50K Franklin research residencies...
The ‘Building Links in Ageing Science and Translation’ (BLAST) network aims to bring people together to form consortia to develop new knowledge and interventions to improve the health of older people. Sara Garcia Rates, COO stated “The BLAST workshop was an excellent...
Susan would like to mention her following thoughts with regards to the OBN presentation: “Our technology is based on the previously unknown neurochemical (T14), that is doubled in the Alzheimer brain. We are developing a pre-symptomatic screen where T14 could be...
Neuro-Bio is delighted to welcome Johnny Thompson as a Consultant. Johnny is a recent neuroscience graduate from the University of Exeter who has a keen interest in Alzheimer’s disease. Johnny has previously worked as a business analyst intern for Ferghana Partners...
